Top

Published in:

01-09-2010 | Original Research Article

Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension

A Randomized, Double-Blind, Parallel-Group, Multicentre, Multinational, Phase III Study

Authors: Prof Roberto Fogari, Stefano Taddei, Merete Holm-Bentzen, Jacek Baszak, Lorenzo Melani, Kai Schumacher

Title: Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension
A Randomized, Double-Blind, Parallel-Group, Multicentre, Multinational, Phase III Study
Authors: Prof Roberto Fogari
Stefano Taddei
Merete Holm-Bentzen
Jacek Baszak
Lorenzo Melani
Kai Schumacher
Publication date: 01-09-2010
Publisher: Springer International Publishing
Published in: Clinical Drug Investigation / Issue 9/2010
Print ISSN: 1173-2563
Electronic ISSN: 1179-1918
DOI: https://doi.org/10.2165/11536710-000000000-00000